Literature DB >> 217832

Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.

M D Trousdale, R E Paque, T Nealon, C J Gauntt.   

Abstract

Ten temperature-sensitive (ts) mutants isolated from a myocarditis-inducing wild-type (WT) coxsackievirus B3 parent did not induce myocarditis in adolescent CD-1 mice. An avirulent prototype ts mutant from one of the three complementation groups adsorbed to murine cardiac tissue, as did WT virus. Heart tissues from mice inoculated with WT virus contained 100- to 1,000-fold more virus than heart tissues from mice inoculated with any of the three prototype ts mutants. WT virus exhibited a greater capsid stability and a higher efficiency of replication at 37 degrees C than any of the three prototype ts mutants. All three prototype ts mutants induced less interferon in vivo than WT virus. Cell-mediated immune responses, assessed by the cell migration inhibition assay, were different in mice inoculated with WT virus when compared to ts 5 mutant virus. Peritoneal exudate cells from mice inoculated with WT but not ts 5 virus reacted specifically against antigens in WT virus HeLa cell lysates and antigens extracted with KCl from cardiac tissues of mice inoculated with WT virus. Cardiac tissues of mice inoculated with WT but not ts 5 virus contained KCl-extractable antigens which were able to specifically inhibit the migration of peritoneal exudate cells taken from mice immunized with WT virus. Therefore, ts 5 neither elicited a measurable cell-mediated immune response nor induced antigens in cardiac tissues which were immunoreactive with sensitized-(WT virus)-peritoneal exudate cells. Of 9 revertant viruses isolated from the 10 ts mutants, 5 showed covariance in ability to replicate at 39.5 degrees C and capacity for induction of myocarditis. Some revertants exhibited a reduced capsid thermostability compared to WT virus but yet retained the capacity for induction of myocarditis. The data suggest that induction of myocarditis by coxsackievirus B3 variants depends on a combination of several variables, including capsid stability, capacity for replication at 37 degrees C, and expression of the three identified genes. All three prototype ts mutants served as vaccine viruses in preventing myocarditis in adolescent mice subsequently challenged with WT virus. However, all three prototype ts mutants and their revertant variants retained partial to complete lethality in CD-1 neonates.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 217832      PMCID: PMC414191          DOI: 10.1128/iai.23.2.486-495.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  The incorporation of neutral red and acridine orange into developing poliovirus particles making them photosensitive.

Authors:  D CROWTHER; J L MELNICK
Journal:  Virology       Date:  1961-05       Impact factor: 3.616

2.  Photodynamic inactivation of viruses.

Authors:  C W HIATT
Journal:  Trans N Y Acad Sci       Date:  1960-11

3.  Myocarditis in newborns, caused by coxsackie virus; clinical and pathological data.

Authors:  H DE JAGER; S VAN CREVELD
Journal:  Ann Paediatr       Date:  1956 Jul-Aug

4.  Myocarditis in the new newborn infant; a study of an outbreak associated with Coxsackie group B virus infection in a maternity home in Johannesburg.

Authors:  S N JAVETT; S HEYMANN; B MUNDEL; W J PEPLER; H I LURIE; J GEAR; V MEASROCH; Z KIRSCH
Journal:  J Pediatr       Date:  1956-01       Impact factor: 4.406

5.  Isolation of Coxsackievirus B3 temperture-sensitive mutants and their assignment to complementation groups.

Authors:  M D Trousdale; R E Paque; C J Gauntt
Journal:  Biochem Biophys Res Commun       Date:  1976-05-23       Impact factor: 3.575

6.  Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.

Authors:  R E Paque; C J Gauntt; T J Nealon; M D Trousdale
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

7.  Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity.

Authors:  J T Harrington; P Stastny
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

8.  On the statistical evaluation of the macrophage migration inhibition assay.

Authors:  H Bergstrand; B Källen
Journal:  Scand J Immunol       Date:  1973       Impact factor: 3.487

9.  Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1.

Authors:  C Y Wong; J J Woodruff; J F Woodruff
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

10.  Biological and chemical characterization of human histocompatibility antigens.

Authors:  R A Reisfeld; B D Kahan
Journal:  Fed Proc       Date:  1970 Nov-Dec
View more
  13 in total

1.  In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

2.  Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants.

Authors:  C J Gauntt; M D Trousdale; J C Lee; R E Paque
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

3.  Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model.

Authors:  C J Gauntt; H M Arizpe; J T Kung; K K Ogilvie; U O Cheriyan
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

4.  Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts.

Authors:  C W Lutton; C J Gauntt
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.

Authors:  H Zhang; G E Yousef; X Ouyang; L C Archard
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

6.  Coxsackievirus B4: in vitro genetic markers and cardiovirulence. Brief report.

Authors:  S Jimes; R M Jamison; W D Grafton
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

7.  Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Authors:  C J Gauntt; R E Paque; M D Trousdale; R J Gudvangen; D T Barr; G J Lipotich; T J Nealon; P S Duffey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  A glyconutritional mixture (Ambrotose®) provides some amelioration to mice with coxsackievirus-induced pancreatitis.

Authors:  C Gauntt; D Busbee; H J Wood; S Reyna; R Barhoumi; R Burghardt; W McAnalley; H R McDaniel
Journal:  Age (Omaha)       Date:  1999-10

9.  Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.

Authors:  C J Gauntt; P T Gomez; P S Duffey; J A Grant; D W Trent; S M Witherspoon; R E Paque
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

10.  Coxsackievirus B4: in vitro genetic markers and virulence.

Authors:  S Jimes; R M Jamison
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.